WallStreetZenWallStreetZen

NASDAQ: ALDX
Aldeyra Therapeutics Inc Stock Ownership - Who owns Aldeyra Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aldeyra Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Perceptive Advisors LLC10% Owner2025-04-033,400,000$1.42
$4.83MSell
Bruce GreenbergInterim Chief Financial Officer2024-08-1210,834$4.74
$51.31kSell
Stephen MacHathaChief Development Officer2024-08-1216,041$4.74
$75.97kSell

1 of 1

ALDX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALDX insiders and whales buy or sell their stock.

ALDX Shareholders

What type of owners hold Aldeyra Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC15.49%9,275,851$35.16MInstitution
Perceptive Advisors LLC14.13%8,465,302$32.08MInsider
Knoll Capital Management LLC9.14%5,475,516$20.75MInstitution
Blackrock Inc6.24%3,736,038$14.16MInstitution
Vanguard Group Inc6.21%3,718,018$14.09MInstitution
Domain Partners VI LP3.29%1,973,389$7.48MInsider
Jesse I. Treu3.15%1,885,854$7.15MInsider
Johnson Johnson2.92%1,750,292$6.63MInsider
Ardsley Advisory Partners LP2.92%1,750,000$6.63MInstitution
Todd C. Brady2.46%1,471,298$5.58MInsider

1 of 3

ALDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALDX63.26%27.92%Net SellingNet Selling
FENC3.74%96.26%Net SellingNet Selling
TVGN2.09%85.17%Net SellingNet Selling
VSTM46.60%53.40%Net SellingNet Selling
NBTX12.15%0.00%
View Top Biotech Stocks

Aldeyra Therapeutics Stock Ownership FAQ

Who owns Aldeyra Therapeutics?

Aldeyra Therapeutics (NASDAQ: ALDX) is owned by 63.26% institutional shareholders, 27.92% Aldeyra Therapeutics insiders, and 8.83% retail investors. Perceptive Advisors LLC is the largest individual Aldeyra Therapeutics shareholder, owning 8.47M shares representing 14.13% of the company. Perceptive Advisors LLC's Aldeyra Therapeutics shares are currently valued at $32.42M.

If you're new to stock investing, here's how to buy Aldeyra Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.